Overview
The EAGLE study is a prospective randomized controlled multicenter parallel design trial, for the assessment of clinical performance of the CADDIE device and to confirm that the device performs as expected.
Description
The EAGLE study will be conducted with a parallel design. Patients who meet the study inclusion/exclusion criteria will be randomized in a 1:1 ratio to receive either computer-aided colonoscopy (CADDIE Arm) using CADDIE or standard colonoscopy without CADe (Control Arm). All resected polyps will be submitted for histologic examination.
Eligibility
Inclusion Criteria:
- Screening or surveillance colonoscopy
- Age 40 years or older
- Informed consent
Exclusion Criteria:
- Emergency colonoscopies
- Inflammatory bowel disease (IBD)
- Colorectal Cancer (CRC)
- Previous Colorectal Cancer (CRC)
- Previous colonic resection
- Returning for a planned elective therapeutic colonoscopy.
- Polyposis syndromes (familial adenomatous polyposis)
- Contraindication for biopsy or polypectomy.